Stroke Management Market Size By Type (Ischemic, Hemorrhagic, Transient Ischemic Attack [TIA]), By Diagnostics (Magnetic Resonance Imaging [MRI], Computed Tomography Scan [CT Scan], Electrocardiography, Carotid Ultrasound, Cerebral Angiography), By Therapeutic Devices (Stent Retriever, Surgical Clipping, Embolic Coils, Flow Diverters, Aspiration Catheters), By End-use (Hospitals, Ambulatory Surgery Centers, Diagnostic Centers), Industry Analysis Report, Regional Outlook (U.S., Canada, Germany, UK, France, Italy, Spain, Russia, Poland, Netherlands, Japan, China, India, Australia, Malaysia, Thailand, Indonesia, South Korea, Brazil, Mexico, Argentina, South Africa, Saudi Arabia, Qatar, UAE), Application Potential, Competitive Market Share & Forecast, 2019 – 2025

Published Date: Jun 2019 | Report ID: GMI3550 | Authors: Sumant Ugalmugale, Shradha Mupid Report Format: PDF

  Request Sample
Summary Table of Contents Industry Coverage Methodology

Industry Trends

Stroke Management Market size was valued at USD 28.3 billion in 2018 and is expected to witness 6.9% CAGR from 2019 to 2025.
 

U.S. Stroke Management Market, By Type, 2018 & 2025 (USD Million)

U.S. Stroke Management Market, By Type, 2018 & 2025 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Rising prevalence of stroke and growing preference for minimally invasive treatment procedures worldwide will positively impact stroke management devices industry growth. Various medical amenities opt for minimally invasive procedures due to progressions in imaging technologies that provide secured patient care. Thus, growing adoption of minimally invasive procedures such as surgical clipping, stenting and angioplasty for treating stroke will boost business growth during the forecast timeline.
 

Advancement in healthcare facilities and technologies for effective stroke diagnosis and treatment will drive industry growth during the analysis period. Development of technologically advanced solutions such as robotic assisted angiography for stroke rehabilitation will favour business growth. Furthermore, adoption of mobile stroke treatment units (MSTU) to treat stroke patients in hospital settings will further spur business revenue. However, stringent regulatory framework may hamper stroke management industry growth over the forecast period.
 

Stroke Management Market, By Type

Ischemic stroke segment held over 81% revenue share in 2018 and is expected to rise significantly by 2025. Segment growth is attributed to globally increasing patient pool suffering from ischemic stroke. Increasing mortality rate should accelerate the adoption of stroke management devices. Focus of industry players on product innovation will favor segmental growth during the forthcoming years.
 

Hemorrhagic segment is anticipated to witness vigorous CAGR of more than 6.5% over the analysis timeframe owing to rising number of hemorrhagic cases in developed as well as developing economies. Obstetric hemorrhage is one of the major causes of maternal mortality. Additionally, increasing obstetric hemorrhage disease prevalence will surge the demand for advanced stroke management, thereby increasing its demand during forthcoming years.
 

Stroke Management Market, By Diagnostics

Carotid ultrasound segment was valued over USD 3.5 billion in 2018 and is assessed to witness similar growth during the forecast period. Increasing patient preference towards safe and painless stroke management procedures will drive segmental growth. Rising incidence of narrowed carotid arteries will surge the demand for diseases diagnosis using ultrasound, thereby upsurging segmental growth in the foreseeable future.
 

Magnetic resonance imaging segment held considerable revenue share in 2018 and is expected to witness around 7.3% CAGR over the forthcoming years. Technology integrated in MRI systems provide physicians with more accurate data as compared to conventional scanning devices in minimum time. It offers retrospective manipulation of images that results in rapid results, thereby increasing its adoption during the analysis timeframe.
 

Germany Stroke Management Market Size, By Therapeutic Devices, 2018 (USD Million)

Germany Stroke Management Market Size, By Therapeutic Devices, 2018 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Stroke Management Market, By Therapeutic Devices

Stent retriever segment accounted for more than 20.5% revenue share in 2018 and will exhibit substantial growth during the forecast period. Increasing adoption of stent retrievers by specialists to retrieve thromboembolus and restore blood flow will surge its demand during the analysis timeframe.
 

Flow diverters segment is anticipated to witness around 6.5% CAGR over the forecast timeline. Wide adoption of flow diverters to treat strokes coupled with availability of technologically advanced products will spur the segment revenue size.
 

Stroke Management Market, By End-use

Diagnostic centers segment held over USD 7.5 billion revenue in 2018 and will exhibit tremendous growth over the forecast timeframe. Availability of technologically advanced medical devices in diagnostic centers and available skilled specialists will accelerate business growth over the coming years.
 

Ambulatory surgical centers (ASCs) segment is estimated to exceed USD 9.5 billion by 2025. Growing patient inclination towards ASCs due to its benefits including limited hospital stays, minimum infection risks, affordable and quality treatments will accelerate business growth during the forecast period.
 

Stroke Management Market, By Region

North America stroke management market will witness around 6.5% CAGR over the analysis timeframe. High prevalence of stenosis, aneurysm and ischemic stroke in the region will aid stroke management business growth. Strong foothold of prominent industry players in the region and focus on novel product development should positively impact North America stroke management business growth.
 

Asia Pacific stroke management market held more than USD 7 billion revenue in 2018. Regional growth is attributed to presence of large patient population. Rising government support along with healthcare reforms in countries such as China will further drive Asia Pacific stroke management industry growth over the coming years.
 

Asia Pacific Stroke Management Market Size, By Country, 2025 (USD Million)

Asia Pacific Stroke Management Market Size, By Country, 2025 (USD Million)

Get more details on this report - Request Free Sample PDF
 

Competitive Market Share

Some of the prominent business players operating in stroke management market include Abbott Laboratories, Asahi Intecc, Boston Scientific, B. Braun, Claret Medical, GE Healthcare, Integer Holdings, Johnson & Johnson, Kaneka Medix, Medtronic, Penumbra, Siemens, Silk Road Medical and Teleflex. These industry players implement various strategies such as collaboration, partnerships and new product launch to maintain their financial stability and capitalize on market opportunities. For instance, in May 2019, B. Braun in collaboration with NuMED Inc., developed NuDEL CP Stent Delivery System for treating right ventricular outflow tract conduit disruptions and coarctation of aorta. The strategy enabled firm to enhance its product portfolio and broaden its customer base.
 

Stroke Management Industry Background

Stroke Management Market Segmentation

Get more details on this report - Request Free Sample PDF
 

Hippocrates, the father of medicine, first recognized stroke more than 2,400 years ago and named the condition as apoplexy. In 1600s, Jacob Wepfer discovered disrupted blood supply in the brains of people that died from apoplexy. Later, medical science continued to make advances concerning the causes, symptoms and treatment of apoplexy, also known as stroke or cerebral vascular accident (CVA). One of the earliest known stroke treatments occurred in the 1800s, when physicians began performing surgery on the carotid arteries. Later, in 1807, the first documented carotid artery surgery was performed in New Hampshire by Dr. Amos Twitchell. In 1990s, stroke treatment was implemented globally and the U.S. Food and Drug Administration (FDA) approved the use of tissue plasminogen activator (TPA). Advent in technology has led to developments in stroke management devices. Focus of industry players on introduction of novel products have led to launch of advanced stroke management devices over the recent years. Rising adoption of such products in various surgical interventions will surge its demand, thus, driving stroke management industry growth during the forthcoming years.
 


What Information does this report contain?

Historical data coverage: 2014 to 2018; Growth Projections: 2019 to 2025.
Expert analysis: industry, governing, innovation and technological trends; factors impacting development; drawbacks, SWOT.
6-7 year performance forecasts: major segments covering applications, top products and geographies.
Competitive landscape reporting: market leaders and important players, competencies and capacities of these companies in terms of production as well as sustainability and prospects.


Premium Report: Details

Pages: 190
Tables: 304
Charts / Figures: 9
Companies covered: 14
Countries covered: 25

Special Requests?

Inquire Before Buying
This site is protected by Trustwave's Trusted Commerce program Authorize.Net Merchant - Click to Verify BBB Rating - Click to Verify

15% Free Customization
Share your Requirements

Customize this Report

Questions? Speak to an Analyst

Full Name *
Email *
Phone (With Country Code)
Message *
Are you human?
5 + 4 =

Your personal details are secure. Privacy Policy

Connect with our sales team

Chat With Us
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. More info. I Agree